Lammer J
Department of Radiology, Karl Franzens University and Medical School, Graz, Austria.
Radiol Clin North Am. 1990 Nov;28(6):1211-22.
Plastic biliary endoprostheses relieved malignant obstructive jaundice in 80% to 90% of the patients. The comfort of a completely indwelling endoprosthesis should be offered to all palliatively treated tumor patients, and external-internal catheters should be reserved for the minority of patients who return with reoccluded endoprostheses. These patients have bacterial flora that rapidly contaminates the endoprosthesis and causes encrustations and reocclusions. Thus, a second endoprosthesis also would reocclude quickly. The mechanism of reocclusion of plastic and metal endoprostheses is completely different. In plastic endoprostheses, bacterial contamination causes decomposition of the bile and subsequent encrustation. In metal endoprostheses tumor ingrowths between the struts of the stent cause reocclusion. Tumor ingrowths were observed in only 6.5% of metal prostheses with a narrow woven mesh (Wallstent), whereas prostheses with large distances between the struts (Gianturco stent) had ingrowth rates of 19% to 50%. This fact shows that tumor ingrowths can be reduced by narrowing the spaces between the metallic network, and, therefore, improvements in the design of the metal stents should reduce the occlusion rate to or below that of plastic endoprostheses, which currently have a lower encrustation rate. The major advantages of expandable metal prostheses are the relative ease and the minimal trauma of the implantation procedure. The Wallstent endoprosthesis, in particular, can be inserted through a 7-F introducer sheath and offers the chance of single-step placement. The 30-day mortality rate, therefore, was only 5%. This is significantly lower than the 30-day mortality rate after insertion of plastic prostheses (15% to 24%). Even simple external catheter drainage procedures have a higher reported 30-day mortality rate (27%). Expandable metal endoprostheses would be the most useful device if the occlusion rate could be kept under 10% in large series. Increasing the length of the endoprostheses to 10 cm in the expanded state could also improve the long-term patency rates.
塑料胆管内支架可使80%至90%的患者恶性梗阻性黄疸得到缓解。对于所有接受姑息治疗的肿瘤患者,都应提供完全植入式内支架所带来的舒适感,而内外引流管应仅保留给少数内支架再堵塞的患者。这些患者的细菌菌群会迅速污染内支架,导致结壳和再堵塞。因此,第二个内支架也会很快再次堵塞。塑料和金属内支架再堵塞的机制完全不同。在塑料内支架中,细菌污染会导致胆汁分解并随后结壳。在金属内支架中,支架支柱之间的肿瘤向内生长会导致再堵塞。在编织网狭窄的金属支架(Wallstent)中,仅6.5%观察到肿瘤向内生长,而支柱间距大的支架(Gianturco支架)向内生长率为19%至50%。这一事实表明,缩小金属网之间的间隙可减少肿瘤向内生长,因此,改进金属支架的设计应可将堵塞率降低至塑料内支架的堵塞率或更低,目前塑料内支架的结壳率较低。可扩张金属支架的主要优点是植入过程相对简便且创伤极小。特别是Wallstent内支架可通过7F引导鞘插入,并提供一步到位放置的机会。因此,30天死亡率仅为5%。这明显低于插入塑料支架后的30天死亡率(15%至24%)。即使是简单的外引流管引流操作,报告的30天死亡率也更高(27%)。如果在大量病例中堵塞率能保持在10%以下,可扩张金属内支架将是最有用的器械。将内支架在扩张状态下的长度增加到10厘米也可提高长期通畅率。